110 related articles for article (PubMed ID: 16133302)
1. [Are polymorphisms in the mu-opioid receptor important for opioid therapy?].
Lötsch J; Freynhagen R; Geisslinger G
Schmerz; 2005 Oct; 19(5):378-82, 384-5. PubMed ID: 16133302
[TBL] [Abstract][Full Text] [Related]
2. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch J; Geisslinger G
Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
[TBL] [Abstract][Full Text] [Related]
3. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers.
Lötsch J; Geisslinger G
Pharmacogenomics J; 2006; 6(3):200-10. PubMed ID: 16415919
[TBL] [Abstract][Full Text] [Related]
4. [Individual differences in analgesic effects of narcotics].
Ide S; Kasai S; Ikeda K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):43-8. PubMed ID: 18411709
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
6. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.
Beyer A; Koch T; Schröder H; Schulz S; Höllt V
J Neurochem; 2004 May; 89(3):553-60. PubMed ID: 15086512
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of opioid analgesia.
Pasternak GW
J Pain Symptom Manage; 2005 May; 29(5 Suppl):S2-9. PubMed ID: 15907642
[TBL] [Abstract][Full Text] [Related]
8. Opioid and adjuvant analgesics: compared and contrasted.
Khan MI; Walsh D; Brito-Dellan N
Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
[TBL] [Abstract][Full Text] [Related]
9. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.
Chaipatikul V; Loh HH; Law PY
J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655
[TBL] [Abstract][Full Text] [Related]
10. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
11. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects.
Kolesnikov Y; Gabovits B; Levin A; Voiko E; Veske A
Anesth Analg; 2011 Feb; 112(2):448-53. PubMed ID: 21127283
[TBL] [Abstract][Full Text] [Related]
12. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
Bayerer B; Stamer U; Hoeft A; Stüber F
Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
[TBL] [Abstract][Full Text] [Related]
13. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers.
Oertel BG; Schmidt R; Schneider A; Geisslinger G; Lötsch J
Pharmacogenet Genomics; 2006 Sep; 16(9):625-36. PubMed ID: 16906017
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm.
Pan L; Xu J; Yu R; Xu MM; Pan YX; Pasternak GW
Neuroscience; 2005; 133(1):209-20. PubMed ID: 15893644
[TBL] [Abstract][Full Text] [Related]
15. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.
Matthes HW; Maldonado R; Simonin F; Valverde O; Slowe S; Kitchen I; Befort K; Dierich A; Le Meur M; Dollé P; Tzavara E; Hanoune J; Roques BP; Kieffer BL
Nature; 1996 Oct; 383(6603):819-23. PubMed ID: 8893006
[TBL] [Abstract][Full Text] [Related]
16. Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy.
Liu YC; Wang WS
Cancer; 2012 Mar; 118(6):1718-25. PubMed ID: 21837673
[TBL] [Abstract][Full Text] [Related]
17. Murine inter-strain polymorphisms alter gene targeting frequencies at the mu opioid receptor locus in embryonic stem cells.
Zhou L; Rowley DL; Mi QS; Sefcovic N; Matthes HW; Kieffer BL; Donovan DM
Mamm Genome; 2001 Oct; 12(10):772-8. PubMed ID: 11668392
[TBL] [Abstract][Full Text] [Related]
18. The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses.
Skorpen F; von Hofacker S; Bjørngaard M; Skogholt AH; Dale O; Kaasa S; Klepstad P
Acta Anaesthesiol Scand; 2016 Sep; 60(8):1084-91. PubMed ID: 27113810
[TBL] [Abstract][Full Text] [Related]
19. In vivo activation of a mutant mu-opioid receptor by antagonist: future direction for opiate pain treatment paradigm that lacks undesirable side effects.
Yang W; Law PY; Guo X; Loh HH
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2117-21. PubMed ID: 12525693
[TBL] [Abstract][Full Text] [Related]
20. Mu opioid receptors in pain management.
Pasternak G; Pan YX
Acta Anaesthesiol Taiwan; 2011 Mar; 49(1):21-5. PubMed ID: 21453899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
